News
The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.
SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
David Mulligan, PhD, previews the FDA's ODAC meeting discussing the application of belantamab mafodotin-based combinations for the treatment of multiple myeloma.
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering substances like LSD and ecstasy should be approved for Americans grappling ...
Some proponents worry they could lose credibility if they are rushed onto the market or are too closely tied to Kennedy.
While advocates focused on Planned Parenthood, the bill did not mention it by name. Instead, it cut off reimbursements for ...
But benzathine penicillin G is the only product that’s approved and recommended to treat the sexually transmitted infection syphilis during pregnancy. If the infection is caught early, a single ...
58mon MSN
NEW YORK (AP) — President Donald Trump is lashing out at his own supporters as he tries to clamp down on criticism over his ...
49m
News Medical on MSNTTUHSC researcher focuses on how brain endothelial cells handle stressors of neuroinflammationEach year in the U.S., approximately 2.5 million people suffer traumatic brain injuries (TBIs). About 50,000 of these injuries will result in death, and more than 80,000 will lead to permanent ...
Nostrum Labs is recalling all lots within expiry of Sucralfate Tablets 1g as the Company has shut down operations at its US sites and is unable to assure the quality of the product.
56m
Everyday Health on MSNLiving a Normal Life With Hereditary Angioedema (HAE)ON THIS PAGECommon ChallengesPregnancyTravelSchool and WorkParentingThrivingLiving with hereditary angioedema (HAE) can be challenging. You may have to pay close attention to potential triggers or ...
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) is one of the 10 Best Small-Cap Stocks to Buy According to Billionaires. On July 10, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results